Weight LossLongevityPeptidesSexual Health: MenSexual Health: WomenHair RestorationAnti-ParasiticSleepSexual Health (all)How it worksFAQAboutContactLog in
Weight Loss · Daily rapid-dissolve tablet

Oral Tirzepatide: dual-action GIP + GLP-1 therapy in one rapid-dissolve tablet

Compounded tirzepatide in a tablet that dissolves in the mouth without water. No needles, one tablet a day, prescribed online when a licensed provider determines it is appropriate.

First month $199 · then $249/mo

Plan availability and pricing vary by state. California has its own pricing, confirmed during your assessment.

Start Assessment
U.S.-licensed providers HIPAA-secure Free discreet shipping Ongoing care included
Oral Tirzepatide rapid-dissolve tablets product photo
Why Oral Tirzepatide

What this treatment offers

Dual-pathway mechanism

Tirzepatide acts on both GIP and GLP-1 receptors, the two incretin pathways studied in clinical research on chronic weight management.

No needles, no water

One rapid-dissolve tablet a day. It dissolves in the mouth without water, so there is no injection and no weekly shot to schedule.

Provider-directed dosing

A licensed provider in your state reviews your history, prescribes only if appropriate, and adjusts your dose over time based on response and tolerability.

Ongoing provider support

Message your care team anytime with questions. If clinically appropriate, your provider may adjust your dose or treatment plan. Refills are managed online and reviewed by a provider when required or when your treatment changes.

Mechanism

The formula: what each pathway does

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Here is what that means, pathway by pathway.

GIP receptor pathway

GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone. Tirzepatide acts on the GIP receptor, a pathway involved in insulin signaling and how the body processes nutrients after meals.

GLP-1 receptor pathway

GLP-1 is the second incretin pathway. Tirzepatide acts on the GLP-1 receptor, which is involved in appetite signaling and blood-sugar regulation and has been studied extensively in weight-management research.

Rapid-dissolve tablet format

The RDT format dissolves in the mouth without water. One tablet a day, no needles, built for patients who prefer an oral routine over a weekly injection.

Pricing

Plans and pricing

Every plan starts with a provider evaluation. Your provider prescribes only if the treatment is appropriate for you.

1
1-month plan
First month $199 · then $249/mo
2
3-month plan
First term $672 · then $747/term
3
6-month plan
First term $1270 · then $1494/term
4
12-month plan
First term $2390 · then $2988/term
How it works

Care without the waiting room

01

Start your assessment

A 5-minute online health questionnaire. No appointment, no waiting room.

02

Provider review

A licensed provider in your state reviews your history and prescribes if appropriate.

03

Pharmacy ships direct

Your medication ships from a licensed U.S. pharmacy in discreet packaging.

04

Ongoing support

Message your care team anytime. Dose questions, refill reviews, and adjustments are handled online when clinically appropriate.

FAQ

Oral tirzepatide questions

How is oral tirzepatide different from the injection?
Same active ingredient, different format. The rapid-dissolve tablet is taken once daily and dissolves in the mouth without water. Your provider can help you decide which format fits your routine and your prescription.
How is tirzepatide different from semaglutide?
Semaglutide acts on GLP-1 receptors. Tirzepatide acts on both GLP-1 and GIP receptors, which is why it is called a dual agonist. Individual results vary.
What are common side effects?
Common side effects of tirzepatide may include nausea, vomiting, diarrhea, constipation, stomach pain, decreased appetite, and indigestion, most often when starting treatment or after a dose increase. Tell your provider about any side effects you experience.
Is compounded oral tirzepatide FDA-approved?
Compounded medications are prepared by licensed pharmacies for individual prescriptions and are not FDA-approved products. Your provider will discuss whether compounded therapy is appropriate for you.
Important safety informationOral tirzepatide is available by prescription only after evaluation by a licensed provider. Compounded medications are prepared for individual patients by licensed pharmacies and are not FDA-approved products. Common side effects of tirzepatide may include nausea, vomiting, diarrhea, constipation, stomach pain, decreased appetite, and indigestion. Rare but serious risks may include pancreatitis and gallbladder problems. In animal studies, tirzepatide caused thyroid C-cell tumors in rats. It is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans. Tell your provider about all medical conditions and medications during your assessment, including any personal or family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2. Individual results vary. This page is educational and is not medical advice.

Ready when you are

Your assessment takes about 5 minutes. A licensed provider takes it from there.

Start Assessment
Weight Loss

Related treatments

Semaglutide product photo

Semaglutide

Weekly injection or daily oral tablet

Compounded semaglutide acts on GLP-1 receptors. Available when prescribed after provider review.

From $79/mo with 12-month plan
Tirzepatide product photo

Tirzepatide

Weekly injection

Compounded tirzepatide acts on both GIP and GLP-1 receptor pathways. Available when prescribed after provider review.

From $99/mo with 12-month plan
Oral TirzepatideFirst month $199 · then $249/mo
Start Assessment